Inducing Immunity Where It Matters: Orthotopic HPV Tumor Models and Therapeutic Vaccinations

Anogenital and oropharyngeal cancers caused by human papillomavirus (HPV) infections account for 4.5% of all cancer cases worldwide. So far, only the initial infection with selected high-risk types can be prevented by prophylactic vaccination. Already existing persistent HPV infections, however, can...

Descripción completa

Detalles Bibliográficos
Autores principales: Zottnick, Samantha, Voß, Alessa L., Riemer, Angelika B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457000/
https://www.ncbi.nlm.nih.gov/pubmed/32922389
http://dx.doi.org/10.3389/fimmu.2020.01750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457000/
https://www.ncbi.nlm.nih.gov/pubmed/32922389
http://dx.doi.org/10.3389/fimmu.2020.01750

Ejemplares similares